Table 1.
Sociodemographic, anthropometric, and clinical parameters in CS and RA patients
| CS (n = 270) | RA (n = 216) | p‐value | |
|---|---|---|---|
| Demographics and anthropometric components | |||
| Sex (Female/Male) | (240/30) | (194/22) | 0.769 |
| Age (years)† | 44 (33–55) | 46 (37−55) | 0.074 |
| Weight (kg)† | 69 (62−81) | 65 (55−73) | 0.0001 |
| Height (cm)† | 1.61 (1.56−1.65) | 1.56 (1.52−1.62) | <0.0001 |
| Waist circumference (cm)† | 98 (88−105) | 96 (87−103) | 0.0877 |
| BMI (kg/m2) ‡ | 27 (23−30) | 26 (23−30) | 0.0703 |
| Systolic pressure (mmHg)† | 116 (105−125) | 120 (108−126) | 0.7302 |
| Diastolic pressure (mmHg)† | 80 (70−82) | 78 (80−82) | 0.4601 |
| Meals per day‡ | 3.53 ± 1.236 | 2.91 ± 0.70 | <0.0001 |
| Physical activity n (%) | |||
| Never | 100 (37) | 68 (32) | 0.343 |
| Occasionally | 59 (22) | 57 (26) | |
| Frequently | 111 (41) | 91 (42) | |
| Smoking index ‡ | 1.46 ± 4.6 | 1.8 ± 4.6 | 0.7580 |
| Characteristics of RA | |||
| DAS‐28 score† | 3.1 (2.1−4.8) | − | |
| Evolution of RA (years)† | − | 7.82 (2−15) | − |
| Rheumatoid factor (UI/ml)† | 137 (20‐712) | − | |
| Drug treatment n (%) | |||
| NSAIDs | − | 189 (70) | − |
| Prednisone | − | 58 (27) | − |
| DMARDs | |||
| Sulfasalazine | − | 73 (34) | − |
| Chloroquine | − | 60 (28) | − |
| Methotrexate | − | 189 (70) | − |
According to the normal distribution, results expressed as median and interquartile ranges, Mann‐Whitney test † or mean ± standard deviation, Student's t test‡. Bold letters indicate statistically significant results.
Abbreviations: CS, control subject; DAS‐28, disease activity score 28; DMARDs, disease‐modifying antirheumatic drugs; NSAIDs, nonsteroidal anti‐inflammatory drugs; RA, rheumatoid arthritis.